ORBIMED ADVISORS LLC
- SEC CIK
- 0001055951
Latest role at each company
- ETRA Electra Therapeutics, Inc.Director, 10% Owneras of Sep 23, 2026
- BLSM BlossomHill Therapeutics, Inc.Directoras of Aug 12, 2026
- BRVE Braveheart Bio, Inc.Director, 10% Owneras of Aug 11, 2026
- SCTX Scribe Therapeutics, Inc.Directoras of Jul 29, 2026
- SION Sionna Therapeutics, Inc.Directoras of Jul 9, 2026
Show 39 more companies
- ELVN Enliven Therapeutics, Inc.10% Owneras of Jun 24, 2026
- STTK Shattuck Labs, Inc.Directoras of Jun 15, 2026
- QTTB Q32 Bio Inc.Director, 10% Owneras of Jun 1, 2026
- TRAW Traws Pharma, Inc.10% Owneras of Apr 28, 2026
- PRLD Prelude Therapeutics IncDirector, 10% Owneras of Apr 23, 2026
- IMA ImageneBio, Inc.Directoras of Apr 16, 2026
- ACET Adicet Bio, Inc.10% Owneras of Apr 9, 2026
- KROS Keros Therapeutics, Inc.Directoras of Dec 18, 2025
- PMVP PMV Pharmaceuticals, Inc.10% Owneras of Oct 27, 2025
- CIK 0001764974Directoras of Aug 12, 2025
- CRVS Corvus Pharmaceuticals, Inc.Director, 10% Owneras of Jul 1, 2025
- PASG Passage BIO, Inc.10% Owneras of Jun 26, 2025
- NPCE NeuroPace Inc10% Owneras of May 16, 2025
- XTNT Xtant Medical Holdings, Inc.10% Owneras of Apr 14, 2025
- CMPX Compass Therapeutics, Inc.Director, 10% Owneras of Apr 11, 2025
- EWTX Edgewise Therapeutics, Inc.Director, 10% Owneras of Apr 4, 2025
- IRON Disc Medicine, Inc.Directoras of Mar 26, 2025
- MBX MBX Biosciences, Inc.Director, 10% Owneras of Feb 19, 2025
- CIK 0001900520Directoras of Nov 5, 2024
- UPB Upstream Bio, Inc.Director, 10% Owneras of Oct 17, 2024
- SPRY ARS Pharmaceuticals, Inc.Directoras of Aug 28, 2024
- CIK 000160495010% Owneras of Aug 15, 2024
- CIK 0001831363Director, 10% Owneras of Jul 17, 2024
- TELA TELA Bio, Inc.10% Owneras of Jul 2, 2024
- CIK 0001626199Directoras of May 20, 2024
- CIK 0001797768Director, 10% Owneras of Apr 5, 2024
- CIK 0001745020Director, 10% Owneras of Feb 14, 2024
- AVBP ArriVent BioPharma, Inc.Director, 10% Owneras of Jan 31, 2024
- DMRA Damora Therapeutics, Inc.10% Owneras of Aug 17, 2023
- CIK 0001657312Directoras of May 15, 2023
- CIK 0001595585Director, 10% Owneras of Nov 25, 2022
- CIK 0001923840Director, 10% Owneras of Sep 21, 2022
- CIK 000177342710% Owneras of Sep 14, 2022
- CIK 0001290149Director, 10% Owneras of Jul 1, 2022
- ARQT Arcutis Biotherapeutics, Inc.10% Owneras of Jun 28, 2022
- CIK 000178517310% Owneras of Jan 27, 2022
- JANX Janux Therapeutics, Inc.Directoras of Dec 30, 2021
- CIK 0001808158Directoras of Sep 8, 2021
- CIK 0001522860Director, 10% Owneras of Jul 21, 2021
Trades
Every Form 4 that lists ORBIMED ADVISORS LLC as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| ETRAElectra Therapeutics, Inc. | Sep 23, 20265:29 PM ET | Sep 21, 2026 | ORBIMED ADVISORS LLC and 2 othersDirector, 10% Owner | PPurchaseCommon Stock | +1.33M | $15.00 | +$20.0M | 1.76M | +313.8% | SEC |
| BLSMBlossomHill Therapeutics, Inc. | Aug 12, 20264:43 PM ET | Aug 10, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | PPurchaseCommon Stock | +625.0K | $16.00 | +$10.0M | 2.71M | +29.9% | SEC |
| BRVEBraveheart Bio, Inc. | Aug 11, 20265:27 PM ET | Aug 7, 2026 | ORBIMED ADVISORS LLC and 2 othersDirector, 10% Owner | PPurchaseCommon Stock | +1.94M | $18.00 | +$34.9M | 273.3K | New position | SEC |
| SCTXScribe Therapeutics, Inc. | Jul 29, 20266:47 PM ET | Jul 27, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | PPurchaseCommon Stock | +1.00M | $15.00 | +$15.0M | 1.35M | +286.7% | SEC |
| SIONSionna Therapeutics, Inc. | Jul 9, 20264:44 PM ET | Jul 7, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −85.9K | $44.86 | −$3.85M | 2.47M | −3.4% | SEC10b5-1 |
| SIONSionna Therapeutics, Inc. | Jul 2, 20264:42 PM ET | Jun 30, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −115.8K | $45.50 | −$5.27M | 2.56M | −4.3% | SEC10b5-1 |
| ELVNEnliven Therapeutics, Inc. | Jun 24, 20267:19 PM ET | Jun 22, 2026 | ORBIMED ADVISORS LLC and 2 others10% Owner | SSaleCommon Stock | −860.1K | $45.3587 | −$39.0M | 6.56M | −11.6% | SEC |
| ELVNEnliven Therapeutics, Inc. | Jun 17, 20267:45 PM ET | Jun 15, 2026 | ORBIMED ADVISORS LLC and 2 others10% Owner | SSaleCommon Stock | −281.4K | $45.02 | −$12.7M | 7.39M | −3.7% | SEC |
| STTKShattuck Labs, Inc. | Jun 15, 20266:12 PM ET | Jun 11, 2026 | ORBIMED ADVISORS LLC and 2 othersDirector | PPurchaseCommon Stock · Derivative | +1.25M | – | – | 5.30M | – | SEC |
| QTTBQ32 Bio Inc. | Jun 1, 20269:13 PM ET | May 28, 2026 | ORBIMED ADVISORS LLC and 2 othersDirector, 10% Owner | PPurchaseCommon Stock | +1.88M | $8.00 | +$15.0M | 625.0K | New position | SEC |
| SIONSionna Therapeutics, Inc. | May 29, 20268:57 PM ET | May 27, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −101 | $44.49 | −$4.49K | 2.67M | 0.0% | SEC10b5-1 |
| SIONSionna Therapeutics, Inc. | May 11, 20266:58 PM ET | May 7 – May 11, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −293.0K | $45.6186 | −$13.4M | 2.67M | −9.9% | SEC10b5-1 |
| TRAWTraws Pharma, Inc. | Apr 28, 20269:41 PM ET | Apr 16, 2026 | ORBIMED ADVISORS LLC and 1 other10% Owner | PPurchaseCommon Stock | +597.7K | $1.67 | +$998.2K | 1.20M | +98.7% | SEC |
| TRAWTraws Pharma, Inc. | Apr 28, 20269:41 PM ET | Apr 16, 2026 | ORBIMED ADVISORS LLC and 1 other10% Owner | PPurchaseCommon Stock · Derivative | +2.99M | – | – | 1.79M | – | SEC |
| PRLDPrelude Therapeutics Inc | Apr 23, 20266:48 PM ET | Apr 21, 2026 | ORBIMED ADVISORS LLC and 3 othersDirector, 10% Owner | PPurchaseCommon Stock | +2.82M | $4.44 | +$12.5M | 1.13M | New position | SEC |
| SIONSionna Therapeutics, Inc. | Apr 21, 20268:40 PM ET | Apr 17 – Apr 18, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −55.3K | $44.6715 | −$2.47M | 2.96M | −1.8% | SEC10b5-1 |
| IMAImageneBio, Inc. | Apr 16, 20267:23 PM ET | Apr 14, 2026 | ORBIMED ADVISORS LLC and 2 othersDirector | PPurchaseCommon Stock · Derivative | +721.3K | – | – | 384.7K | – | SEC |
| SIONSionna Therapeutics, Inc. | Apr 16, 20267:03 PM ET | Apr 14 – Apr 16, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −510.6K | $44.9389 | −$22.9M | 3.02M | −14.5% | SEC10b5-1 |
| ACETAdicet Bio, Inc. | Apr 9, 20265:38 PM ET | Apr 7 – Apr 8, 2026 | ORBIMED ADVISORS LLC and 7 others10% Owner | SSaleCommon Stock | −104.7K | $6.4481 | −$674.8K | 0 | −100.0% | SEC |
| SIONSionna Therapeutics, Inc. | Feb 4, 20267:39 PM ET | Feb 2 – Feb 3, 2026 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −31.0K | $44.5794 | −$1.38M | 3.53M | −0.9% | SEC10b5-1 |
| SIONSionna Therapeutics, Inc. | Dec 29, 20258:44 PM ET | Dec 24, 2025 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −33.4K | $44.55 | −$1.49M | 3.56M | −0.9% | SEC10b5-1 |
| SIONSionna Therapeutics, Inc. | Dec 19, 20257:29 PM ET | Dec 17 – Dec 19, 2025 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −1.88K | $44.4948 | −$83.4K | 3.60M | −0.1% | SEC10b5-1 |
| SIONSionna Therapeutics, Inc. | Nov 26, 20256:45 PM ET | Nov 24 – Nov 26, 2025 | ORBIMED ADVISORS LLC and 1 otherDirector | SSaleCommon Stock | −108.1K | $44.5459 | −$4.81M | 3.60M | −2.9% | SEC10b5-1 |
| PMVPPMV Pharmaceuticals, Inc. | Oct 27, 20255:19 PM ET | Oct 23, 2025 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −1.00M | $1.52 | −$1.52M | 4.98M | −16.7% | SEC |
| ACETAdicet Bio, Inc. | Oct 10, 20258:06 PM ET | Oct 8, 2025 | ORBIMED ADVISORS LLC and 7 others10% Owner | PPurchaseCommon Stock | +5.00M | $1.00 | +$5.00M | 4.49M | New position | SEC |
| PMVPPMV Pharmaceuticals, Inc. | Sep 12, 20255:09 PM ET | Sep 10, 2025 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −500.0K | $1.80 | −$900.0K | 5.98M | −7.7% | SEC |
| STTKShattuck Labs, Inc. | Sep 2, 20259:52 PM ET | Aug 25, 2025 | ORBIMED ADVISORS LLC and 2 othersDirector | PPurchaseCommon Stock | +6.31M | $0.8677 | +$5.47M | 1.05M | New position | SEC |
| STTKShattuck Labs, Inc. | Sep 2, 20259:52 PM ET | Aug 25, 2025 | ORBIMED ADVISORS LLC and 2 othersDirector | PPurchaseCommon Stock · Derivative | +30.6M | – | – | 3.07M | – | SEC |
| CRVSCorvus Pharmaceuticals, Inc. | Jul 1, 20259:23 PM ET | Jun 27, 2025 | ORBIMED ADVISORS LLC and 1 otherDirector, 10% Owner | SSaleCommon Stock | −1.18M | $4.1586 | −$4.89M | 7.17M | −14.1% | SEC |
| PASGPassage BIO, Inc. | Jun 26, 20255:10 PM ET | Jun 24 – Jun 26, 2025 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −583.7K | $0.3379 | −$197.2K | 6.07M | −8.8% | SEC |
| NPCENeuroPace Inc | May 16, 20255:26 PM ET | May 14, 2025 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −168.1K | $15.8522 | −$2.67M | 3.24M | −4.9% | SEC |
| PASGPassage BIO, Inc. | Apr 24, 20255:38 PM ET | Apr 22 – Apr 24, 2025 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −235.6K | $0.3342 | −$78.7K | 6.65M | −3.4% | SEC |
| PASGPassage BIO, Inc. | Apr 17, 20256:10 PM ET | Apr 15 – Apr 17, 2025 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −149.1K | $0.3335 | −$49.7K | 6.89M | −2.1% | SEC |
| XTNTXtant Medical Holdings, Inc. | Apr 14, 20257:14 PM ET | Apr 10, 2025 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −73.1M | $0.42 | −$30.7M | 0 | −100.0% | SEC |
| CMPXCompass Therapeutics, Inc. | Apr 11, 20257:24 PM ET | Apr 9, 2025 | ORBIMED ADVISORS LLC and 2 othersDirector, 10% Owner | SSaleCommon Stock | −3.57M | $1.59 | −$5.68M | 0 | −100.0% | SEC |
| EWTXEdgewise Therapeutics, Inc. | Apr 4, 20257:33 PM ET | Apr 3, 2025 | ORBIMED ADVISORS LLC and 2 othersDirector, 10% Owner | PPurchaseCommon Stock | +496.8K | $20.13 | +$10.0M | 443.8K | New position | SEC |
| IRONDisc Medicine, Inc. | Mar 26, 20257:00 PM ET | Mar 24, 2025 | ORBIMED ADVISORS LLC and 3 othersDirector | SSaleCommon Stock | −5.74K | $54.11 | −$310.5K | 186.5K | −3.0% | SEC |
| IRONDisc Medicine, Inc. | Mar 21, 20258:00 PM ET | Mar 19 – Mar 21, 2025 | ORBIMED ADVISORS LLC and 3 othersDirector | SSaleCommon Stock | −52.4K | $54.0157 | −$2.83M | 187.3K | −21.9% | SEC |
| IRONDisc Medicine, Inc. | Mar 12, 20259:34 PM ET | Mar 10 – Mar 12, 2025 | ORBIMED ADVISORS LLC and 3 othersDirector | SSaleCommon Stock | −312.4K | $54.3101 | −$17.0M | 194.2K | −61.7% | SEC |
| MBXMBX Biosciences, Inc. | Feb 19, 20255:52 PM ET | Feb 14 – Feb 18, 2025 | ORBIMED ADVISORS LLC and 2 othersDirector, 10% Owner | PPurchaseCommon Stock | +190.7K | $10.5981 | +$2.02M | 747.9K | +34.2% | SEC |
| SIONSionna Therapeutics, Inc. | Feb 10, 20254:28 PM ET | Feb 10, 2025 | ORBIMED ADVISORS LLC and 1 otherDirector | PPurchaseCommon Stock | +550.0K | $18.00 | +$9.90M | 3.70M | +17.4% | SEC |
| TRAWTraws Pharma, Inc. | Jan 27, 20257:03 PM ET | Dec 29, 2024 | ORBIMED ADVISORS LLC and 1 other10% Owner | PPurchaseCommon Stock · Derivative | +192.7K | – | – | 96.3K | – | SEC |
| PASGPassage BIO, Inc. | Jan 14, 20255:17 PM ET | Jan 10 – Jan 14, 2025 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −223.2K | $0.6371 | −$142.2K | 7.03M | −3.1% | SEC |
| PASGPassage BIO, Inc. | Jan 8, 20256:09 PM ET | Jan 6 – Jan 8, 2025 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −147.0K | $0.7026 | −$103.3K | 7.26M | −2.0% | SEC |
| PASGPassage BIO, Inc. | Dec 26, 20244:34 PM ET | Dec 20, 2024 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −230.3K | $0.60 | −$138.2K | 7.40M | −3.0% | SEC |
| PASGPassage BIO, Inc. | Dec 11, 20245:32 PM ET | Dec 9 – Dec 11, 2024 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −62.3K | $0.8348 | −$52.0K | 7.64M | −0.8% | SEC |
| PASGPassage BIO, Inc. | Dec 6, 20247:07 PM ET | Dec 4 – Dec 6, 2024 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −97.1K | $0.7965 | −$77.3K | 7.70M | −1.2% | SEC |
| UPBUpstream Bio, Inc. | Oct 17, 20244:17 PM ET | Oct 15, 2024 | ORBIMED ADVISORS LLC and 3 othersDirector, 10% Owner | PPurchaseCommon Stock | +825.0K | $17.00 | +$14.0M | 4.55M | +22.1% | SEC |
| PASGPassage BIO, Inc. | Sep 23, 20244:51 PM ET | Sep 19, 2024 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −39.3K | $0.71 | −$27.9K | 7.79M | −0.5% | SEC |
| PASGPassage BIO, Inc. | Sep 18, 20246:38 PM ET | Sep 16 – Sep 18, 2024 | ORBIMED ADVISORS LLC and 1 other10% Owner | SSaleCommon Stock | −200.1K | $0.7332 | −$146.7K | 7.83M | −2.5% | SEC |